We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
The 2013-2018 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in India
Price data last checked 44 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 47 days · 47 data points (no recent data)
Price Distribution
Price distribution over 47 days • 1 price levels
Price Analysis
Most common price: £495 (47 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 47 days
Product Specifications
- Format
- paperback
- ASIN
- B00B548ABG
- Domain
- Amazon UK
- Release Date
- 09 January 2013
- Listed Since
- 24 January 2013
Similar Products You Might Like
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Greater China
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Japan
The 2013-2018 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in India
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in the United States
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in Japan
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control in Greater China
The 2016 Report on Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control: World Market Segmentation by City
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Americas
The 2013-2018 Outlook for Drugs in India
The 2013-2018 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in India
The 2013-2018 Outlook for Synthetic Organic Medicinal Chemicals, Medicinal and Botanical Drugs and Chemicals in Bulk, Alkaloid Drugs, and Naturally Occurring Vitamins in India
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Asia
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Oceana
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Middle East
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Europe
The 2013-2018 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in India
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Africa
The 2013-2018 Outlook for Neurostimulation Devices in India
The 2013-2018 Outlook for Neurostimulation Devices in North America & the Caribbean
The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East
The 2023-2028 Outlook for Cognitive and Memory Enhancer Drugs in China
The 2013-2018 Outlook for Photoresists and Ancillaries in India
The 2013-2018 Outlook for Neurostimulation Devices in Latin America
